Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Lung Injury, Acute

erlotinib hydrochloride has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, L; Li, N; Meng, C; Mu, H; Tao, H; Xia, H; Xu, Y; Zhang, S; Zhang, Z1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Lung Injury, Acute

ArticleYear
Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway.
    Shock (Augusta, Ga.), 2019, Volume: 51, Issue:1

    Topics: Acute Lung Injury; Animals; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Toll-Like Receptor 4

2019